Connect with us

Technology

Alan announces a €480 million financing round to make prevention insurance the new global standard in healthcare

Published

on

Backed by Prosus, Alan enters a new phase of growth to transform healthcare through prevention, technology and AI

PARIS, June 25, 2026 /PRNewswire/ – Alan, the company building the new standard in prevention insurance, today announced an agreement for a Series G financing round of €480 million ($550 million), valuing the company at €5.5 billion ($6.3 billion). The round is led by Prosus, one of the world’s largest technology operators and investors based in the Netherlands, alongside existing shareholders Teachers’ Venture Growth (TVG) and Index Ventures as well as new investors Dara Holdings. The closing of this financing round is subject to applicable regulatory approvals, including from the relevant French financial authorities.

This financing marks a major milestone in Alan’s journey and reflects a growing conviction that healthcare must evolve from a system focused on treating illness to one built around prevention, continuous care, and long-term health outcomes. There is today a unique opportunity to accelerate this with AI.

Over the past decade, Alan has evolved beyond its origins as a health insurer to pioneer a new category: prevention insurance. Healthcare today is built on waiting – for a six-month appointment, for symptoms to get worse, for insurance that only steps in once you are already sick. Alan is built to do the opposite: to act before health problems become bigger problems. It is the first company to bring insurance, prevention and care together in a single integrated experience – combining health coverage, care navigation, wellbeing services and AI-powered health assistance so members can act early, stay on top of their health and feel more in control every day.

With this new financing, Alan enters a new phase of growth with the ambition to make prevention insurance the preferred model for healthcare. The company plans to accelerate the expansion of its model in several new countries across the world, deepen its presence in existing markets including France, Belgium, Spain and Canada, pursue acquisitions, and continue investing heavily in artificial intelligence, healthcare services and product innovation.

The company enters this new chapter from a position of considerable strength. In Q1 2026, the company reached more than €800 million in Annual Recurring Revenue, grew 53% year-over-year, surpassed 1.1 million members and is profitable in France.

Alan believes AI will fundamentally transform healthcare by making personalized prevention, navigation and support available to everyone. Combined with Alan’s integrated healthcare platform, these technologies have the potential to improve outcomes for millions of people while reducing the long-term cost of care.

Prosus brings to this next phase a unique track record of supporting category-defining technology companies around the world. With deep expertise in scaling consumer platforms and a global network built over decades of investment, Prosus will support Alan’s ambition to redefine healthcare for the digital age.

Commenting on this announcement,  Jean-Charles Samuelian-Werve, Co-founder and CEO of Alan, said: “Health can’t wait, not for symptoms to get worse, not for a six-month appointment, not for the system to catch up. Yet that is exactly how healthcare works today. We believe great health is a universal right, and that prevention should be too. For ten years we have shown that technology can turn healthcare from reactive to proactive, helping people act early instead of reacting late. That is what prevention insurance is, and it’s the category we are building. We selected Prosus for their very deep expertise in international expansion and consumer products and to benefit from the incredible ecosystem they are building. We are still at the very beginning of what Alan can become.”

“Healthcare presents one of the most significant global opportunities for AI-led transformation,” said Fahd Beg, Head of Investments at Prosus Group. “Alan has built something unique: an integrated platform where insurance, prevention and care delivery reinforce each other, creating an exceptional healthcare experience for consumers and outstanding platform engagement. We’re excited to partner with Alan to accelerate its international expansion and unlock value through our ecosystem.”

About Alan

Alan is building the new standard in prevention insurance — the first company to bring insurance, prevention and care together in a single experience, serving more than 1.1 million members. Rather than only covering people when something goes wrong, Alan helps them stay one step ahead: acting before health problems become bigger problems and staying in control of their health every day. Alan is an independent company regulated by the French Prudential Supervision and Resolution Authority (ACPR). Members benefit from an integrated solution designed to support both their physical and mental wellbeing while simplifying their healthcare experience through seven-day-a-week customer support, access to doctors directly through the platform, and reimbursement services known for their reliability and speed. The company operates in four countries – France, Spain, Belgium and Canada – and serves more than 37,000 businesses as well as self-employed professionals and retirees. With a team of more than 850 people, Alan is dedicated to delivering an outstanding member experience, reflected in consistently high satisfaction ratings (above 4.2/5). Alan generates more than €800 million in Annual Recurring Revenue and is valued at €5.5 billion in 2026.

Media contacts:

Alexandra van Weddingen

Eléonore Barreyre

Alva Conseil

Alva Conseil

+33611011791

+ 33648175222

avanweddingen@alvaconseil.com

 ebarreyre@alvaconseil.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/alan-announces-a-480-million-financing-round-to-make-prevention-insurance-the-new-global-standard-in-healthcare-302809870.html

SOURCE Alan

Continue Reading

Technology

TECNO Wins Two IFA Global Product Technology Innovation Awards for Modular Phone and Tonino Lamborghini TECNO TAURUS

Published

on

By

BERLIN, Sept. 5, 2026 /PRNewswire/ — TECNO, a global AI-driven innovative technology brand, achieved two IFA Global Product Technology Innovation Awards at IFA 2026:

Tonino Lamborghini TECNO TAURUS took the Miniaturized Gaming PC Technology Innovation Gold Award, standing out with its Italian aesthetics and exceptional performance in the compact body. The TECNO Modular Phone was honored with the Ultra-Slim Magnetic Modular Technology Innovation Gold Award, praised for its ultra-slim craftsmanship and unique modular magnetic technology.

These awards once again demonstrate TECNO’s sustained breakthroughs in product innovation and industry-leading craftsmanship in design excellence. The Global Product Technology Innovation Awards were established in 2014 by IDG, IFA, and DIHK to celebrate excellence across the global consumer electronics industry. The awards honor products that set new industry benchmarks and drive innovation through intelligent technology and user-centric design.

TECNO Modular Phone: The World’s Thinnest Modular Smartphone

At just 4.9mm, the TECNO Modular Phone is powered by proprietary Modular Magnetic Interconnection Technology. It combines a precision magnetic array with pogo-pin connectors, offering a flexible ecosystem for different needs. The host retains a 3000–4000mAh battery, while modules draw power directly for a snap-and-go experience. It also resolves the inherent conflict between rising AI computing demands and limited device space.

The technology has earned over 20 accolades from leading media, with CNET and Yanko Design naming it the Best of MWC 2026, and The Verge recognizing it as the Best Mobile Tech at MWC 2026.

Tonino Lamborghini TECNO TAURUS: One of the World’s Smallest Water-Cooling Gaming Mini-PCs

At around 6.36 liters, the panoramic transparent chassis of the Tonino Lamborghini TECNO TAURUS fuses iconic Italian design with raw engineering. Powered by the Intel® Core™ i9-13900HK and NVIDIA® GeForce RTX™ 5060 (614 AI TOPS, 145W TGP, DLSS 4), it achieves the pinnacle of performance, providing a high-fidelity gaming experience and high-efficiency AI workstation. The water-cooling system sustains peak frequencies, while 15 ports and WiFi 6E deliver connectivity. It was recognized with Yanko Design’s Best of MWC award.

In addition, TECNO made waves at IFA with the Next-Gen Bezelless Concept Phone featuring a revolutionary 0mm screen bezel, and the convertible laptop MEGABOOK T15 360 Pro. Relentlessly pushing the boundaries of design, performance, and AI innovation, TECNO is pioneering limitless possibilities for futuristic technology.

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/tecno-wins-two-ifa-global-product-technology-innovation-awards-for-modular-phone-and-tonino-lamborghini-tecno-taurus-302870739.html

Continue Reading

Technology

Morpho UV Printer Unveiled at IFA with Hands-On Live Creation

Published

on

By

BERLIN, Sept. 5, 2026 /PRNewswire/ — Morpho, a company specializing in UV printing technology, is showcasing its first desktop UV printer at IFA 2026, Hall 17-196. Visitors are observing Morpho’s colorful, textured prints, and some have the opportunity to print on a range of blank materials provided.

Morpho’s desktop UV printer can print on a wide range of materials, including wood, glass, leather, metal, and more, delivering vivid colors and tactile textures for customized results. At IFA 2026, the booth attracted interest from creators, educators, and technology professionals, who gathered to watch live demonstrations.

Among those who have tried Morpho’s printer, three aspects are most frequently highlighted: print quality, the moving gantry design, and overall ease of use.

Visitors are first drawn to the prints, which feature precise color reproduction and finely detailed textile textures. With G7 Master ColorSpace certification, Morpho ensures consistent tones across different pieces. The same level of precision is evident in the raised textures created by the industrial-grade printhead, which builds fine layers of ink for detailed, tactile surfaces. The printhead maintains fast carriage motion speeds of up to 600mm/s while preserving precise detail.

Attendees have also noted the printer’s compact desktop footprint. With its moving gantry architecture—where the entire gantry moves along both axes—the printer offers a large, fully enclosed print chamber that accommodates various objects while remaining desktop-friendly.

First-time users have given positive feedback on Morpho’s usability. The integrated Stereo Vision Smart Alignment™ System quickly captures an object’s height and contours, while Morpho Studio’s guided workflows help users move from idea to print with minimal setup.

Morpho’s team shared that the program has been in development for several years, with the goal of making UV printers a practical tool for everyday creative use. Founder Mingyu “Brett” Wang, formerly Global VP of R&D at DJI, commented, “We communicate directly with our community, listen to feedback, and make fast improvements.”

Ahead of IFA, Morpho’s Kickstarter campaign surpassed $10 million in support from over 2,800 backers worldwide. The company is committed to further developing its proprietary core technology and delivering reliable engineering for creators, makers, and small businesses.

Visit Morpho’s website to learn more.

About Morpho: Morpho develops desktop UV printers that bring industrial-grade printing and coloring to everyday materials, enabling creators to turn almost any physical surface into a canvas for their ideas.

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/morpho-uv-printer-unveiled-at-ifa-with-hands-on-live-creation-302870741.html

Continue Reading

Technology

Society of Robotic Surgery and Puma Venture Capital Announce Winners of SRS Shark Tank 2026

Published

on

By

Drive Medical claimed the top prize at the third annual SRS Shark Tank 2026, held during the Society of Robotic Surgery’s annual conference at the Diplomat Beach Resort in Hollywood, Florida. The event, a collaboration between SRS and Puma Venture Capital, once again showcased cutting-edge innovations in the digital and robotic surgery ecosystem and featured early-stage companies poised to transform minimally invasive care.

HOLLYWOOD, Fla., Sept. 5, 2026 /PRNewswire-PRWeb/ — Drive Medical claimed the top prize at the third annual SRS Shark Tank 2026, held during the Society of Robotic Surgery’s annual conference at the Diplomat Beach Resort in Hollywood, Florida. The event, a collaboration between SRS and Puma Venture Capital, once again showcased cutting-edge innovations in the digital and robotic surgery ecosystem and featured early-stage companies poised to transform minimally invasive care.

SRS Shark Tank 2026 featured presentations from nine innovative companies. Each had five minutes to pitch their technology and five minutes to engage in a Q&A session with a panel of esteemed judges, including top surgeons, investors, and medical device experts. Companies were evaluated on innovation, impact on healthcare, market potential, business model, and presentation.

Drive Medical earned the top honor for the Pollywog System, the first easy-to-use robotic endoscope integrated with artificial intelligence. The platform is designed to give physicians faster, safer access to the small bowel, allowing diagnosis and treatment to be completed in a single session rather than across multiple procedures.

DeepQure secured second place with HyperQure, the world’s first extravascular renal denervation system for resistant hypertension. Delivered laparoscopically, the device wraps the renal artery from the outside to achieve complete denervation while avoiding the vessel lining.

Microsure came in third with MUSA-3, a microsurgical robot that downscales and stabilizes a surgeon’s hand movements during open super-microsurgical procedures, including free flap, lymphatic, and peripheral nerve surgery. The system received CE mark approval earlier this year.

The strength of the 2026 field extended well beyond the podium: every one of the nine presenting companies was placed in the top three by at least one judge. Reveal Surgical presented optical imaging technology that characterizes tissue for tumor assessment during surgery, and Symphera demonstrated a laparoscopic system that lets surgeons switch instrument tips at the push of a button. Tioga Cardiovascular showed its transcatheter approach to mitral and tricuspid valve replacement.

CardioSentry presented an AI platform for autonomous cardiac ultrasound, and Nina Medical showcased a completely non-invasive treatment for benign prostatic hyperplasia. LITLab rounded out the slate with mobile, high-fidelity surgical training labs that travel to health systems and medtech companies to train clinical teams onsite. Together the group reflected an unusually broad and competitive slate, spanning robotics, imaging, structural heart, urology, and surgical education.

The 2026 judging panel included Steve Bell, Rob Morgan, Dr. Santiago Horgan, Dr. Erik B. Wilson, Scott Zinober, and Babak Tehranchi, and the event was co-chaired by Amit Hazan and Dr. Vipul Patel.

Participating companies included:

Microsure, Symphera, LITLab, Reveal Surgical, DeepQure, Drive Medical, Nina Medical, CardioSentry, and Tioga Cardiovascular.

About the Society of Robotic Surgery:

Founded in 2012, the Society of Robotic Surgery (SRS) is guided by the fundamental principles of education and collaboration as a means to tackle the complex issues of robotic surgery. The SRS’ membership includes more than 20,000 physicians of all disciplines from around the world whose mission is to share information related to multi-centric studies, database collection, fellowship training and funding support related to robotic surgery. The SRS is the only multi-specialty robotic surgery society in the world with an annual meeting that includes updates in more than a dozen medical sub-specialties along with state-of-the-art plenary sessions and hot topic courses.

About Puma Venture Capital:

Puma Venture Capital is an investment firm seeking to leverage its surgeon venture partners to invest in all aspects of physical intelligence across every medical procedure — to improve patient outcomes, lift labor productivity, and lower system costs.

Media Contact

Ryan Julison, Society of Robotic Surgery, 1 3213776877, ryanjulison@gmail.com

View original content:https://www.prweb.com/releases/society-of-robotic-surgery-and-puma-venture-capital-announce-winners-of-srs-shark-tank-2026-302869733.html

SOURCE Society of Robotic Surgery

Continue Reading

Trending